We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+4.9%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$3.9B
AUM Growth
+$213M
(+5.8%)
Cap. Flow
+$73M
Cap. Flow
% of AUM
1.87%
Top 10 Holdings %
Top 10 Hldgs %
36.05%
Holding
3,497
New
199
Increased
1,347
Reduced
1,062
Closed
172
Avg Time Held Equity + Options
4.3
years
Top 10 Avg Time Held Equity + Options
2
years
Top 20 Avg Time Held Equity + Options
3.2
years
Avg Time Held Equity only
4.3
years
Top 10 Avg Time Held Equity only
2
years
Top 20 Avg Time Held Equity only
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$79.4M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$52M |
| 3 |
Apple
AAPL
|
+$6.85M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$6.48M |
| 5 |
Fidelity Total Bond ETF
FBND
|
+$5.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$52.1M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$44M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$9.53M |
| 4 |
NVIDIA
NVDA
|
+$4.49M |
| 5 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$3.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.08% |
| 2 | Technology | 16.58% |
| 3 | Healthcare | 8.56% |
| 4 | Financials | 6.53% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3051
DELISTED
Select Medical
SEM
| $596 | ﹤0.01% |
32
+17
| +113% | +$290 |
2023 Q4
2 quarters
|
|
3052
DELISTED
Direxion Moonshot Innovators ETF
MOON
| $595 | ﹤0.01% |
63
| – | – |
2023 Q3
3 quarters
|
|
|
AVDL
3053
DELISTED
Avadel Pharmaceuticals
AVDL
| $591 | ﹤0.01% |
42
| – | – |
2023 Q1
5 quarters
|
|
3054
Regenxbio
RGNX
$473M
| $585 | ﹤0.01% |
50
| – | – |
2020 Q1
17 quarters
|
|
3055
Orion Energy Systems
OESX
$95.1M
| $584 | ﹤0.01% |
53
| – | – |
2021 Q1
13 quarters
|
|
3056
Cannae Holdings
CNNE
$704M
| $580 | ﹤0.01% |
32
-166
| -84% | -$3.22K |
2023 Q4
2 quarters
|
|
3057
BioCryst Pharmaceuticals
BCRX
$2.05B
| $575 | ﹤0.01% |
+93
| New | +$513 |
2024 Q2
0 quarters
|
|
3058
DELISTED
Squarespace, Inc.
SQSP
| $567 | ﹤0.01% |
13
+5
| +63% | +$200 |
2022 Q4
6 quarters
|
|
3059
Astronics
ATRO
$2.65B
| $561 | ﹤0.01% |
34
| – | – |
2023 Q1
5 quarters
|
|
3060
CleanSpark
CLSK
$2.4B
| $558 | ﹤0.01% |
+35
| New | +$588 |
2024 Q2
0 quarters
|
|
3061
Horace Mann Educators
HMN
$1.86B
| $555 | ﹤0.01% |
17
| – | – |
2021 Q1
13 quarters
|
|
3062
RUM Group Inc
RUM
$2.46B
| $555 | ﹤0.01% |
100
| – | – |
2022 Q3
7 quarters
|
|
3063
Grupo Aval
AVAL
$5.82B
| $554 | ﹤0.01% |
254
-74
| -23% | -$175 |
2019 Q1
21 quarters
|
|
3064
Pediatrix Medical
MD
$2.26B
| $551 | ﹤0.01% |
73
-30
| -29% | -$248 |
2016 Q4
30 quarters
|
|
3065
3D Systems Corp
DDD
$492M
| $550 | ﹤0.01% |
179
+95
| +113% | +$348 |
2016 Q4
30 quarters
|
|
3066
Inseego
INSG
$73M
| $533 | ﹤0.01% |
50
| – | – |
2020 Q2
16 quarters
|
|
3067
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $533 | ﹤0.01% |
38
-22
| -37% | -$284 |
2023 Q2
4 quarters
|
|
3068
Equinox Gold
EQX
$13B
| $528 | ﹤0.01% |
101
| – | – |
2022 Q4
6 quarters
|
|
3069
Montauk Renewables
MNTK
$302M
| $524 | ﹤0.01% |
+92
| New | +$425 |
2024 Q2
0 quarters
|
|
3070
Tilray
TLRY
$474M
| $520 | ﹤0.01% |
31
| – | – |
2018 Q3
23 quarters
|
|
3071
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$145M
| $517 | ﹤0.01% |
+16
| New | +$507 |
2024 Q2
0 quarters
|
|
3072
Tempest Therapeutics
TPST
$10.7M
| $517 | ﹤0.01% |
+18
| New | +$779 |
2024 Q2
0 quarters
|
|
3073
ePlus
PLUS
$2.48B
| $516 | ﹤0.01% |
7
-9
| -56% | -$688 |
2020 Q4
14 quarters
|
|
3074
Allogene Therapeutics
ALLO
$463M
| $515 | ﹤0.01% |
+221
| New | +$652 |
2024 Q2
0 quarters
|
|
3075
Suburban Propane Partners
SPH
$1.15B
| $513 | ﹤0.01% |
27
| – | – |
2023 Q1
5 quarters
|
|
Similar funds
Parallel Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Parallel Advisors held 3,497 positions worth $3.9B, up 5.8% from $3.69B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Parallel Advisors's Q2 2024 filing shows 199 new, 1,347 increased, 1,062 reduced and 172 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 24,596 shares worth $1.28M. The largest sale was iShares MSCI USA Quality Factor ETF, an estimated $52.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 49% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2024 buy was BlackRock Flexible Income ETF: 24,596 shares worth $1.28M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $79.4M increase.
- Parallel Advisors's biggest Q2 2024 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $52.1M.
- Parallel Advisors fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $974K.
- Parallel Advisors's ten largest holdings make up 36% of its $3.9B portfolio in Q2 2024.
- Parallel Advisors opened 199 new positions and closed 172 in Q2 2024.
- Parallel Advisors's portfolio value rose 5.8% quarter-over-quarter to $3.9B.
Based on Parallel Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.